Latest Regulatory Change News

Page 13 of 30
Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.
Victor Sage
Victor Sage
29 Jan 2026
CAQ Holdings reported an 8% drop in leasing revenue for the December 2025 quarter amid persistently high vacancy rates, yet anticipates improved rental income following new tenancy negotiations on Hainan Island.
Eva Park
Eva Park
27 Jan 2026
EDU Holdings Limited anticipates FY25 financial results near the top of its guidance, driven by strong revenue and profit growth from its higher education arm, Ikon Institute.
Victor Sage
Victor Sage
27 Jan 2026
Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.
Claire Turing
Claire Turing
22 Jan 2026
Australian Dairy Nutritionals reported a 152% surge in nutritional powder sales despite regulatory hurdles in Vietnam, while expanding its Future brand footprint across China.
Victor Sage
Victor Sage
21 Jan 2026
Ragnar Metals has confirmed high-grade uranium mineralisation at surface over a 150m strike at its Klockartorpet Project in Sweden, revealing a 1km long uranium anomaly and multiple untested targets. The findings set the stage for further exploration and drilling plans.
Maxwell Dee
Maxwell Dee
13 Jan 2026
Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.
Maxwell Dee
Maxwell Dee
2 Jan 2026
Arena REIT reports a $61 million uplift in portfolio valuation for H1 FY2026, driven by strong investor interest in early learning centres and a tightening yield environment. The company reaffirms its FY2026 distribution guidance, signaling confidence in its growth trajectory.
Eva Park
Eva Park
18 Dec 2025
Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.
Ada Torres
Ada Torres
18 Dec 2025
Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.
Victor Sage
Victor Sage
17 Dec 2025
4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.
Ada Torres
Ada Torres
12 Dec 2025
NH3 Clean Energy progresses its WAH2 Project through the FEED phase while forging a pivotal MoU with Japanese giant ITOCHU Corporation to develop clean ammonia bunkering in the Asia Pacific region by 2030.
Maxwell Dee
Maxwell Dee
9 Dec 2025

Browse the archive

Full archive